Oxford COVID-19 vaccine to begin phase II/III human trials !!
The phase I trial in healthy adult volunteers began in April. More than 1,000 immunisations have been completed and follow-up is currently ongoing. The next study will enroll up to 10,260 adults and children and will involve a number of partner institutions across all over the country. The phase II part of the study involves expanding the age range of people the vaccine is assessed in, to include a small number of older adults and children’s: Aged 56-69 Aged over 70 Aged between 5-12 years For these groups, researchers will be assessing…